Close

Oxford Immunotec (OXFD) Receives Favorable Recommendation in Tuberculosis Test Patent Spat

Go back to Oxford Immunotec (OXFD) Receives Favorable Recommendation in Tuberculosis Test Patent Spat

Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation

September 1, 2016 7:03 AM EDT

OXFORD, United Kingdom and MARLBOROUGH, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, today announced that the U.S. Magistrate Judge in the Companys patent infringement lawsuit against Qiagen, Inc., Quest Diagnostics, Inc. and Laboratory Corporation of America Holdings has issued a recommendation denying in substantial part the defendants motion to dismiss the Companys claims.  In issuing his recommendation, the magistrate judge stated, At this early juncture, the Court concludes... More